Special Report
Global Leaders Signal a Confident New Chapter for Cell and Gene Therapy at GenScript Global Forum London 2025
GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, successfully hosted the GenScript Biotech Global Forum ...
November 24, 2025 | News
Mabwell Secures NMPA Approval to Begin Phase II Trial of First-in-Class Anti-IL-11 Antibody for Pathological Scarring
Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that its novel anti‑IL‑11 monoclonal antibody...
November 12, 2025 | News
Bio-Techne and Nucleai Demonstrate Predictive Power of Spatial Biomarkers in Melanoma
Clinical trial data demonstrates how Bio-Techne's spatial biology technology and Nucleai's AI-powered multimodal platforms can identify predictive biomar...
November 05, 2025 | News
Phenomix’s MyPhenome Test Validates GLP-1 Response Prediction Across 88,000 Patients
Studies presented at Obesity Week 2025 validate the test's ability to predict weight-loss response to GLP-1 drugs like semaglutide, including in ...
November 05, 2025 | Report
Novartis Review Reveals Fear of Recurrence as a Major Unmet Need in Breast Cancer Survivorship Across Asia Pacific and the Middle East
A new targeted literature review finds the fear of recurrence a major unmet need in breast cancer survivorship, often found to affect at least two in fiv...
October 31, 2025 | Report
WuXi AppTec Reports RMB32.86 Billion Revenue for First Three Quarters of 2025, Up 18.6% Year-on-Year
Q3 Total Revenue: RMB12.06 Billion, Up 15.3% YoY; Revenue from Continuing Operations[1]Reached RMB12.04 Billion, Up 19.7% YoY Q1-Q3 Total Re...
October 27, 2025 | Company results
ACM Biolabs and National Cancer Centre Singapore Report Encouraging Asia-Based Early Clinical Findings for ACM-CpG Nanoparticle Immunotherapy
ACM Biolabs, a clinical-stage biotechnology company developing next-generation nanoparticle-based immunotherapies, announced encouraging early clinica...
October 23, 2025 | News
AdvanCell’s Lead-212 Radioligand Therapy Shows Strong Safety and Efficacy in Phase 1b Trial for Metastatic Prostate Cancer
Results from the TheraPb Phase 1b dose escalation presented at ESMO 2025 show a promising therapeutic index for 212Pb-ADVC001 in patients with metastat...
October 22, 2025 | News
Aurion Biotech Data Supports Advancing High-Dose AURN001 Regenerative Cell Therapy to Phase 3 Trial in 2026
Data strongly supports advancing high dose AURN001 regenerative cell therapy for patients with corneal endothelial disease to pivotal Phase 3 trial in H1...
October 20, 2025 | News
Daiichi Sankyo and AstraZeneca’s DATROWAY Combination Delivers 68.2% Response and 95.5% Disease Control in First-Line Metastatic Urothelial Cancer
A confirmed objective response rate of 68.2% and a disease control rate of 95.5% was observed with Daiichi Sankyo and AstraZeneca’s DATROWAY in c...
October 20, 2025 | News
Merck Presents Longer-Term Phase 3 Data Showing Pimicotinib Achieves 76.2% Objective Response Rate in TGCT
With median follow-up of 14.3 months, pimicotinib demonstrated increasing ORR over time, from 54% at Week 25 to 76.2% Global Phase 3 MANEUVER study de...
October 20, 2025 | News
Building Trust Through Quality: How QMS Powers Manufacturing Excellence in Life Sciences
Life sciences sector, a robust Quality Management System (QMS) has become the cornerstone of manufacturing excellence. This is especially true for the medi...
October 16, 2025 | Analysis
Pictor Unveils High-Performance PictVet™ Assay for Early Detection of Mycoplasma bovis in Cattle
Mycoplasma bovis is a devastating pathogen that threatens cattle health and productivity worldwide. In the United States alone, economic losses d...
October 16, 2025 | News
Building Biopharma Resilience: Cytiva’s Joonho Choi on the Power of Connected Ecosystems
Amid global supply chain disruptions, tightening regulations, and shifting patient needs, biopharma resilience has become both a stra...
October 15, 2025 | Interview
Most Read
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
